BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
1.350
+0.310 (29.81%)
Nov 11, 2026, 1:15 PM EST - Market open
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $25.09 million as of November 11, 2026. It is the 37,010th most valuable company in the world and the 5,176th biggest in the United States.
Market Cap
25.09M
Enterprise Value
19.35M
1-Year Change
n/a
Global Rank
Country Rank
#5,176 United States
Category
ChartMarket Cap Chart
Since August 7, 2026, BioStem Technologies's market cap has decreased from $69.50M to $25.09M, a decrease of -63.90%. That is a compound annual growth rate of -98.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 10, 2026 | 18.60M | -7.00% |
| Nov 9, 2026 | 20.00M | -0.99% |
| Nov 6, 2026 | 20.20M | 8.60% |
| Nov 5, 2026 | 18.60M | -9.27% |
| Nov 4, 2026 | 20.50M | - |
| Nov 3, 2026 | 20.50M | -0.97% |
| Nov 2, 2026 | 20.70M | 3.50% |
| Oct 30, 2026 | 20.00M | -13.04% |
| Oct 29, 2026 | 23.00M | -14.81% |
| Oct 28, 2026 | 27.00M | 2.27% |
| Oct 27, 2026 | 26.40M | -4.00% |
| Oct 26, 2026 | 27.50M | -1.79% |
| Oct 23, 2026 | 28.00M | -5.41% |
| Oct 22, 2026 | 29.60M | -1.33% |
| Oct 21, 2026 | 30.00M | 2.39% |
| Oct 20, 2026 | 29.30M | 6.55% |
| Oct 19, 2026 | 27.50M | -26.27% |
| Oct 16, 2026 | 37.30M | 2.47% |
| Oct 15, 2026 | 36.40M | -3.45% |
| Oct 14, 2026 | 37.70M | -6.22% |
| Oct 13, 2026 | 40.20M | -7.80% |
| Oct 12, 2026 | 43.60M | -1.13% |
| Oct 9, 2026 | 44.10M | -6.37% |
| Oct 8, 2026 | 47.10M | 10.30% |
| Oct 7, 2026 | 42.70M | -3.17% |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 21.36M |
| CervoMed | 20.73M |
| IGC Pharma | 20.26M |
| Cocrystal Pharma | 19.84M |
| Pasithea Therapeutics | 19.17M |
| Tvardi Therapeutics | 18.81M |
| aTyr Pharma | 18.54M |
| Quoin Pharmaceuticals | 17.92M |